NAGE vs XPEV · P/E 59, rev $61.3M vs rev $895.7M
Niagen Bioscience, Inc. (NAGE) versus Xpeng Inc (XPEV) — a side-by-side from cached financials, not a winner call.
Niagen Bioscience, Inc. (NAGE) is a biotechnology company listed on US.
Xpeng Inc (XPEV) is a auto manufacturers company listed on US. It is led by Xiaopeng He.
Latest reported NAGE revenue for 2026-06-30 was $61.3M. Net income was $7.3M. Revenue was up 94.6% from 2026-03-31 to 2026-06-30. NAGE currently screens at market cap $836.5M and trailing P/E 59.0.
Latest reported XPEV revenue for 2020-12-31 was $895.7M. Net income was -$418.7M. XPEV currently screens at market cap $20.28B.
NAGE currently screens at market cap $836.5M and trailing P/E 59.0. XPEV currently screens at market cap $20.28B.
Not investment advice. Open the NAGE and XPEV stock pages for the full models.
Not investment advice.